• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Revolution Medicines Presents Daraxonrasib in First-Line at 2026

    GLOBENEWSWIRE

    Revolution Medicines To Unveil Daraxonrasib Phase 3 Results

    GLOBENEWSWIRE

    Revolution Medicines` Cancer Pill Boosts Late-Stage Survival

    GLOBENEWSWIRE

    Quanta Shows: Multi-KRAS Inhibitors Beat Pan-RAS Resistance

    GLOBENEWSWIRE

    Revolution Medicines Announces 2025 Results and Updates

    GLOBENEWSWIRE

    Revolution Medicines Starts Rasolute 304 Trial For Daraxonrasib

    GLOBENEWSWIRE

    Revolution Medicines` Daraxonrasib Gets FDA Orphan Status

    GLOBENEWSWIRE

    Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236)

    GLOBENEWSWIRE

    Revolution Begin RASolute 303 Trial for Pancreatic Adenocarcinoma

    GLOBENEWSWIRE

    Revolution Wins FDA Breakthrough Tag for Daraxonrasib

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.